Physician profile
Daniel J Gagne
NPI 1518974336
$1,172.74
in general payments reported to CMS, 2019-2025
22 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.83 · 2021: $12.02 · 2022: $21.55 · 2023: $231 · 2024: $274 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $333.37 | 2019-2025 | Wegovy, Saxenda |
| Lilly USA, LLC | $212.63 | 2024-2025 | Zepbound, Mounjaro |
| W. L. Gore & Associates, INC. | $98.96 | 2021-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Medtronic, INC. | $50.62 | 2023-2025 | V-Loc 180, Absorbatack |
| Smith+Nephew, INC. | $44.44 | 2025 | Stravix Pl, Collagenase Santyl |
| Boston Scientific Corporation | $44.07 | 2025 | Spyglass Discover |
| Ethicon US, LLC | $42.71 | 2025 | Echelon Circular |
| Braintree Laboratories, INC. | $36.59 | 2023 | Sutab |
| Access Pro Medical, LLC | $34.91 | 2023 | Matriderm |
| Solventum Corporation | $34.91 | 2024-2025 | Activ.A.C., 3m Cavilon, V.A.C. Veraflo |
| Conmed Corporation | $34.62 | 2024-2025 | Airseal, Visiclear |
| Organogenesis INC. | $29.62 | 2024 | |
| Shire North American Group INC | $22.45 | 2019 | |
| Distalmotion US | $21.64 | 2025 | Dexter L6 Robot |
| Kerecis Limited | $19.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $19.42 | 2025 | Myrisk |
| Aroa Biosurgery Incorporated | $17.95 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $17.18 | 2025 | |
| Tela Bio, INC. | $16.34 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Urgo Medical North America, LLC | $15.00 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Integra Lifesciences Corporation | $14.73 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Endo Pharmaceuticals INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gagne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.